Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10036 | 1034 | 42.2 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CXCR3 | Author keyword | 69 | 43% | 12% | 122 |
2 | CXCL10 | Author keyword | 37 | 33% | 9% | 93 |
3 | CXCL9 | Author keyword | 22 | 48% | 3% | 34 |
4 | CXCL11 | Author keyword | 14 | 44% | 2% | 24 |
5 | INTERFERON GAMMA INDUCIBLE PROTEIN 10 | Author keyword | 9 | 40% | 2% | 18 |
6 | IP 10 | Author keyword | 8 | 17% | 4% | 41 |
7 | CXCL10 IP 10 | Author keyword | 6 | 47% | 1% | 9 |
8 | MED SURG MATERNAL PEDIAT ADULT SCI | Address | 4 | 50% | 1% | 6 |
9 | MONOKINE INDUCED BY INTERFERON GAMMA MIG | Author keyword | 4 | 75% | 0% | 3 |
10 | ITAC | Author keyword | 4 | 46% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CXCR3 | 69 | 43% | 12% | 122 | Search CXCR3 | Search CXCR3 |
2 | CXCL10 | 37 | 33% | 9% | 93 | Search CXCL10 | Search CXCL10 |
3 | CXCL9 | 22 | 48% | 3% | 34 | Search CXCL9 | Search CXCL9 |
4 | CXCL11 | 14 | 44% | 2% | 24 | Search CXCL11 | Search CXCL11 |
5 | INTERFERON GAMMA INDUCIBLE PROTEIN 10 | 9 | 40% | 2% | 18 | Search INTERFERON+GAMMA+INDUCIBLE+PROTEIN+10 | Search INTERFERON+GAMMA+INDUCIBLE+PROTEIN+10 |
6 | IP 10 | 8 | 17% | 4% | 41 | Search IP+10 | Search IP+10 |
7 | CXCL10 IP 10 | 6 | 47% | 1% | 9 | Search CXCL10+IP+10 | Search CXCL10+IP+10 |
8 | MONOKINE INDUCED BY INTERFERON GAMMA MIG | 4 | 75% | 0% | 3 | Search MONOKINE+INDUCED+BY+INTERFERON+GAMMA+MIG | Search MONOKINE+INDUCED+BY+INTERFERON+GAMMA+MIG |
9 | ITAC | 4 | 46% | 1% | 6 | Search ITAC | Search ITAC |
10 | CXCR3 ANTAGONIST | 3 | 100% | 0% | 3 | Search CXCR3+ANTAGONIST | Search CXCR3+ANTAGONIST |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IP 10 | 97 | 47% | 15% | 154 |
2 | CHEMOKINE RECEPTOR CXCR3 | 74 | 45% | 12% | 122 |
3 | ACTIVE GRAVES DISEASE | 37 | 75% | 3% | 27 |
4 | I TAC | 34 | 49% | 5% | 51 |
5 | CELL ALPHA CHEMOATTRACTANT | 33 | 61% | 3% | 35 |
6 | INDUCIBLE PROTEIN 10 | 32 | 28% | 9% | 98 |
7 | RECEPTOR CXCR3 | 32 | 51% | 4% | 44 |
8 | MIG | 24 | 40% | 5% | 47 |
9 | ALPHA CHEMOKINE CXCL10 | 21 | 75% | 1% | 15 |
10 | TARGETING CCR5 | 21 | 85% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases | 2014 | 39 | 131 | 41% |
CXCR3 ligands: redundant, collaborative and antagonistic functions | 2011 | 188 | 172 | 49% |
CXCL10: A candidate biomarker in transplantation | 2012 | 28 | 103 | 58% |
CXCR3 in T cell function | 2011 | 88 | 160 | 39% |
CXCR3 ligands in disease and therapy | 2015 | 2 | 270 | 40% |
CXCR3 in carcinoma progression | 2015 | 1 | 62 | 61% |
CXCR3, a double-edged sword in tumor progression and angiogenesis | 2013 | 15 | 84 | 55% |
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications | 2011 | 86 | 112 | 31% |
The interaction between CXCL10 and cytokines in chronic inflammatory arthritis | 2013 | 13 | 38 | 42% |
Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum | 2010 | 80 | 159 | 26% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED SURG MATERNAL PEDIAT ADULT SCI | 4 | 50% | 0.6% | 6 |
2 | AMSTERDAM LEIDEN IMMUNOL | 2 | 67% | 0.2% | 2 |
3 | US VET IMMUNE REAGENT NETWORK | 2 | 67% | 0.2% | 2 |
4 | ALI EBN ABITALEB HOSP | 2 | 33% | 0.4% | 4 |
5 | BELO HORIZONTE CITY HLTH | 1 | 100% | 0.2% | 2 |
6 | HOST DEF VIRAL ENGN CYTOKINES GRP | 1 | 50% | 0.2% | 2 |
7 | IMR S1016UMR 8104 | 1 | 100% | 0.2% | 2 |
8 | SYST MANIFESTAT HEPATITIS VIRUSES | 1 | 30% | 0.3% | 3 |
9 | AG KLIN BIOCHEM | 1 | 40% | 0.2% | 2 |
10 | CLIN EXPT MED SURG F MAGRASSI A LANZARA | 1 | 17% | 0.5% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000202700 | CCR2 ANTAGONIST//CCR2//CCR2 ANTAGONISTS |
2 | 0.0000196697 | IMMUNOBIOL ROBERT H LURIE CANC//EXPT CLIN NEUROL//MS CLIN |
3 | 0.0000165567 | THYMUS AND ACTIVATION REGULATED CHEMOKINE//TARC//CCR4 |
4 | 0.0000137501 | LYMPHOTACTIN//CTAP III//CHEMOKINE STRUCTURE |
5 | 0.0000099311 | EOTAXIN//CCR3//RANTES |
6 | 0.0000089344 | CCL20//CCR6//MACROPHAGE INFLAMMATORY PROTEIN 3 ALPHA |
7 | 0.0000088401 | CXCR2//CXCR1//G31P |
8 | 0.0000084054 | BB 10010//CK BETA 8//STEM CELL INHIBITOR |
9 | 0.0000082343 | INTESTINAL EPITHELIAL//CRI 4U004B//LUMINAL CYTOKINES |
10 | 0.0000078285 | CXCR4//CXCR7//CXCL12 |